Feature

A New Route for RGC Survival?

Vascularizing retinal organoids offers new possibilities for preserving retinal ganglion cells inside organoids

  • By

  • February 18, 2026

  • 2 min

Share

Recent advancements in ophthalmological research reveal a method for creating transiently vascularized human retinal organoids (vROs) that significantly enhance retinal ganglion cell (RGC) survival and maturation. By incorporating endothelial cells derived from human induced pluripotent stem cells, researchers have addressed a critical limitation of traditional organoids, which often suffer from hypoxia due to lack of vascularization. This innovative approach could greatly improve modeling of retinal diseases such as glaucoma and diabetic retinopathy, providing valuable platforms for future therapeutic development.

Original Source(s)

A New Route for RGC Survival?

Vascularizing retinal organoids offers new possibilities for preserving retinal ganglion cells inside organoids

  • February 18, 2026

  • 2 min

Related Content

Retinal AI Predicts Neonatal Lung Disease

Retinal scans already performed in the NICU could flag infants at risk for serious lung disease before standard diagnosis

EYP-1901 for Retinal Exudative Diseases

An overview of the current status of the EYP-1901 clinical trial program in wet AMD and DME, presented at Hawaiian Eye and Retina 2026

When the Kidney Meets the Retina

New study suggests potential causal link between kidney disease and AMD

  • January 22, 2026

  • 3 min